Position in NVS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$541,154
+$9,890 QoQ
Shares Held
3,453
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#855
of 1,603 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verity & Verity, LLC holds $179,692,626 across 7 Drug Manufacturers - General names. NVS ranks #6 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
178,972 | $45,036,514 | |
| 2 | AMGN |
Amgen Inc
|
104,299 | $37,768,753 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
272,652 | $34,446,853 | |
| 4 | PFE |
Pfizer Inc
|
1,338,533 | $32,231,874 | |
| 5 | JNJ |
Johnson & Johnson
|
115,000 | $29,206,549 | |
| 6 | NVS |
Novartis AG
This page
|
3,453 | $541,154 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,587 | $460,929 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $541,154 | 3,453 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $531,264 | 3,478 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $520,872 | 3,778 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $484,490 | 3,778 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $457,175 | 3,778 | Shares | Sole | 2025-08-12 | |
| 2020-12-31 | $299,626 | 3,173 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $294,620 | 3,388 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $5,870,296 | 67,212 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $5,607,424 | 68,010 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||